Monoclonal antibody against CGRP (TEV-48125) for preventive treatment of episodic cluster headache: a phase II randomized clinical trial protocol. PPCR [Internet]. 2018 Jul. 25 [cited 2024 Nov. 22];4(1):14-20. Available from: https://journal.ppcr.org/index.php/ppcrjournal/article/view/53